Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Observation
|
Mid-range Performer
364.1500
0.45
(
0.12
%)
NSE
Sep 08, 2025
15:31 PM
25.14% Gain from 52W Low
Volume:
1.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
30 Dec 2020
US FDA Observation
364.15
0.12%
Company Update:Biocon
Buy:
Biocon Ltd.
by
Axis Direct
Target: 505
Target
Axis Direct
We have increased our target price to INR 505 (PEx 32x to FY23E earnings).
Biocon Ltd. is trading
below its 30 day SMA
of 365.7
More from Biocon Ltd.
Recommended
IPOs this week: Seven upcoming listings, Urban Company plus ten new issues
|
08 Sep 2025, 05:30PM
Market closes higher, Ujjivan SFB plans to raise around Rs 2,000 crore via a QIP
Trendlyne Marketwatch |
08 Sep 2025, 03:59PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020